Series E - Epic Sciences

Series E - Epic Sciences

Investment Firm

Overview

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

Announced Date

Sep 12, 2018

Closed on Date

Sep 12, 2018

Funding Type

Series E

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorAlexandria Venture Investments
Participant InvestorViventures
Participant InvestorVarian
Participant InvestorGenomic Health
Participant InvestorDomain Associates

Round Details and Background

Epic Sciences raised $52000000 on 2018-09-12 in Series E

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 30, 2009
Series A - Epic Sciences
1-2.5M
Jun 01, 2015
Debt Financing - Epic Sciences
1-15.0M
Jul 30, 2014
Series C - Epic Sciences
5-30.0M
Nov 13, 2012
Series B - Epic Sciences
3-13.0M

Recent Activity

There is no recent news or activity for this profile.